Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 231

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Dipeptidyl Peptidase-IV Inhibitor Use Associated With Increased Risk of ACE Inhibitor-Associated Angioedema

Open access
Brown, Nancy J., Byiers, Stuart, Carr, David, Maldonado, Mario, Warner, Barbara Ann · 2009 · Hypertension

Abstract

Dipeptidyl peptidase-IV (DPP-IV) inhibitors decrease degradation of the incretins. DPP-IV inhibitors also decrease degradation of peptides, such as substance P, that may be involved in the pathogenesis of angiotensin-converting enzyme (ACE) inhibitor-associated angioedema. This study tested the hypothesis that DPP-IV inhibition affects risk of clinical angioedema, by comparing the incidence of angioedema in patients treated with the DPP-IV inhibitor vildagliptin versus those treated with comparator in Phase III randomized clinical trials. Prospectively defined angioedema-related events were adjudicated in a blinded fashion by an internal medicine adjudication committee and expert reviewer. Concurrent ACE inhibitor or angiotensin receptor blocker exposure was ascertained from case report forms. Study drug exposure was ascertained from unblinded data from phase III studies. Odds ratios and 95% confidence intervals comparing angioedema risk in vildagliptin-treated and comparator-treated patients were calculated for the overall population and for patients taking ACE inhibitors or angiotensin receptor blockers, using both an analysis of pooled data and a meta-analysis (Peto method). Overall, there was no association between vildagliptin use and angioedema. Among individuals taking an ACE inhibitor, however, vildagliptin use was associated with an increased risk of angioedema (14 confirmed cases among 2754 vildagliptin users versus 1 case among 1819 comparator users: odds ratio 4.57 [95% confidence interval 1.57 to 13.28]) in the meta-analysis. Vildagliptin use may be associated with increased risk of angioedema among patients taking ACE inhibitors, although absolute risk is small. Physicians confronted with angioedema in a patient taking an ACE inhibitor and DPP-IV inhibitor should consider this possible drug–drug interaction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/hypertensionaha.109.134197

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 22

  1. 10.1210/jc.2004-2460 · DOI · Paper page
  2. 10.1055/s-2006-944546 · DOI · Paper page
  3. 10.1007/s00125-006-0416-z · DOI · Paper page
  4. 10.1210/jc.2006-1009 · DOI · Paper page
  5. 10.2337/diacare.28.8.1936 · DOI · Paper page
  6. 10.1111/j.1463-1326.2007.00744.x · DOI · Paper page
  7. 10.1161/hyp.31.6.1299 · doi:10.1161/hyp.31.6.1299
  8. 10.1161/hyp.39.2.460 · doi:10.1161/hyp.39.2.460
  9. 10.1001/jama.298.2.194 · DOI · Paper page
  10. 10.1016/S1047-2797(97)00084-7 · DOI
  11. 10.1016/j.clinthera.2006.10.007 · DOI · Paper page
  12. 10.1186/1472-6823-8-14 · DOI
  13. 10.1016/j.iac.2006.08.001 · DOI · Paper page
  14. 10.1056/NEJM198305053081802 · DOI · Paper page
  15. Ahmad S, Wang L, Ward PE. Dipeptidyl(amino)peptidas IV and aminopeptidase M metabolize circulating substance P in vivo. J Pharmacol Exp Ther. 1992; 260: 1257–1261. · DOI
  16. 10.1124/jpet.103.064105 · DOI · Paper page
  17. 10.1001/jama.1988.03410070095035 · DOI · Paper page
  18. 10.1111/j.1524-6175.2003.01924.x · DOI
  19. 10.1016/j.amjhyper.2003.09.014 · DOI · Paper page
  20. 10.1038/nm0897-904 · DOI · Paper page
  21. 10.2337/diacare.21.4.597 · DOI · Paper page
  22. 10.1016/S0140-6736(00)02596-4 · DOI · Paper page

Cited by

See all 231

Metadata

Authors
Brown, N. J., Byiers, S., Carr, D., Maldonado, M., & Warner, B. A.
Venue
Hypertension
Published
2009-09
Volume
54
Issue
3
Pages
516-523
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W2114792859
Cited by
231
References
14
FWCI
7.81
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dipeptidyl Peptidase-IV Inhibitor Use Associated With Increased Risk of ACE Inhibitor-Associated Angioedema. https://app.cochat.ai/papers/10.1161/hypertensionaha.109.134197
The paper
Brown, N. J., Byiers, S., Carr, D., Maldonado, M., & Warner, B. A. (2009). Dipeptidyl Peptidase-IV Inhibitor Use Associated With Increased Risk of ACE Inhibitor-Associated Angioedema. Hypertension. https://doi.org/10.1161/hypertensionaha.109.134197

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.